Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance
Mandy Lawson, Natalie Cureton, Susana R�os, Azadeh Cheraghchi-Bashi, Jelena Urosevic, Sophie D’Arcy and 24 more
- Rank
- 39 of 327
- Percentile
- top 12%
- Where
- Cancer Research, 2023
- Citations
- 71
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.